Laboratory Medicine ›› 2022, Vol. 37 ›› Issue (9): 904-906.DOI: 10.3969/j.issn.1673-8640.2022.09.024
Received:2021-02-02
Revised:2022-04-08
Online:2022-09-30
Published:2022-10-25
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2022.09.024
| 项目 | 甲胎蛋白/ （ng/mL） | 癌胚抗原/ （ng/mL） | 糖类抗原19-9/（U/mL） | t-PSA/ （ng/mL） | f-PSA/ （ng/mL） | f-PSA/t-PSA |
|---|---|---|---|---|---|---|
| 检测结果 | 3.10 | 1.59 | 12.7 | 0.273 | 3.800 | 13.92 |
| 参考区间 | <8 | <3.4 | <22 | <3 | <0.75 | 0.25~1.00 |
| 项目 | 甲胎蛋白/ （ng/mL） | 癌胚抗原/ （ng/mL） | 糖类抗原19-9/（U/mL） | t-PSA/ （ng/mL） | f-PSA/ （ng/mL） | f-PSA/t-PSA |
|---|---|---|---|---|---|---|
| 检测结果 | 3.10 | 1.59 | 12.7 | 0.273 | 3.800 | 13.92 |
| 参考区间 | <8 | <3.4 | <22 | <3 | <0.75 | 0.25~1.00 |
| 方法 | t-PSA/ （ng/mL） | f-PSA/ （ng/mL） | f-PSA/t-PSA比值 |
|---|---|---|---|
| 本例体检者 | |||
| 电化学发光法 | |||
| 第1次检测 | 0.273 | 3.800 | 13.92 |
| 第2次检测 | 0.274 | 5.150 | 18.86 |
| PEG处理后 | 0.238 | 0.104 | 0.44 |
| 微粒子化学发光法 | 0.270 | 0.110 | 0.41 |
| 正常对照者 | |||
| 第1次检测 | 0.794 | 0.216 | 0.27 |
| PEG处理后 | 0.644 | 0.148 | 0.23 |
| 方法 | t-PSA/ （ng/mL） | f-PSA/ （ng/mL） | f-PSA/t-PSA比值 |
|---|---|---|---|
| 本例体检者 | |||
| 电化学发光法 | |||
| 第1次检测 | 0.273 | 3.800 | 13.92 |
| 第2次检测 | 0.274 | 5.150 | 18.86 |
| PEG处理后 | 0.238 | 0.104 | 0.44 |
| 微粒子化学发光法 | 0.270 | 0.110 | 0.41 |
| 正常对照者 | |||
| 第1次检测 | 0.794 | 0.216 | 0.27 |
| PEG处理后 | 0.644 | 0.148 | 0.23 |
| [1] | 龚博文. 临床免疫检验自动化研究进展[J]. 黑龙江科学, 2019, 10(24):76-77. |
| [2] | 唐古生, 沈茜. 临床免疫检测的干扰因素和解决方法[C]. 中华医学会第七次全国中青年检验医学学术会议论文汇编, 2012. |
| [3] |
FAHIE-WILSON M, SMITH T P. Determination of prolactin:the macroprolactin problem[J]. Best Pract Res Clin Endocrinol Metab, 2013, 27(5):725-742.
DOI URL |
| [4] | 黎锦, 李一荣. 内源性抗体对临床免疫检测的干扰及对策[J]. 中华检验医学杂志, 2016, 39(11):811-813. |
| [5] | 张小云, 李娜, 张少玲, 等. 一例促肾上腺皮质激素异常升高的案例分析[J]. 中华临床实验室管理电子杂志, 2018, 6(3):190-192. |
| [6] | 秦雪君, 李扬宇, 林伯熹, 等. 检测干扰导致2例CA19-9假性升高的处理及分析[J]. 检验医学与临床, 2020, 17(13):1949-1951. |
| [7] | 邢淑清, 艾合买提江·吐乎提, 魏子祥, 等. 异嗜性抗体干扰甲状腺激素检测结果的临床病例分析[J]. 国际检验医学杂志, 2020, 41(4):478-480. |
| [8] | 汪怀周, 贺铮雯, 鲁琼, 等. 异嗜性抗体干扰引起血清多项肿瘤标志物显著升高1例[J]. 检验医学, 2019, 34(11):1054-1056. |
| [9] |
ADAMCZYK M, BRASHEAR R J, MATTINGLY P G. Coprevalence of autoantibodies to cardiac troponin I and T in normal blood donors[J]. Clin Chem, 2010, 56(4):676-677.
DOI PMID |
| [10] |
PEDROSA W, TEIXEIRA L. Interference of heterophilic antibodies with free prostate-specific antigen in the Beckman-Coulter(Unicel DxI) assay,inverting the free/total prostate-specific antigen ratio[J]. Ann Clin Biochem, 2009, 46(Pt 4):344-345.
DOI URL |
| [11] |
PREISSNER C M, DODGE L A, O'KANE D J, et al. Prevalence of heterophilic antibody interference in eight automated tumor marker immunoassays[J]. Clin Chem, 2005, 51(1):208-210.
PMID |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
